지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한외과학회 Annals of Surgical Treatment and Research Annals of Surgical Treatment and Research Vol.102 No.2
- 발행연도
- 2022.2
- 수록면
- 65 - 72 (8page)
이용수
초록· 키워드
오류제보하기
Purpose: Various hemostatic agents have been introduced in therapy as postoperative bleeding is a poor prognostic factor for postoperative outcomes. These products can be divided into those that directly promote the hemostatic cascade and those that physically form a barrier by absorbing blood. The latter, powder-type hemostatic agents have the advantages of being inexpensive and more absorbable with less foreign body reactions (FBRs) and are applicable to a relatively wide area. This study was conducted to verify the safety and efficacy of a newly invented polysaccharide product (OOZFIX, Theracion Biomedical), which improves blood absorption and hemostatic effects.
Methods: Two separate animal experiments were performed. The first evaluated FBRs histologically at 3 days, 2 weeks, and 4 weeks, after implantation of OOZFIX in rats, and the second compared hemostatic performance of OOZFIX and Arista AH (Bard) in the porcine liver punch biopsy model.
Results: We found minimal FBRs in the 3-day group and no reactions in both the 2-week and 4-week groups after implantation of hemostatic agents. The time to hemostasis of OOZFIX was not significantly different from that of Arista AH (median [interquartile range]: 9 [6–10] minutes vs. 8 [6–10] minutes, respectively; P = 0.522). When comparing the serial bleeding grade tendency, there was no statistical difference between OOZFIX and Arista AH (P = 0.656).
Conclusion: OOZFIX caused a minimal FBR that disappeared within 2 weeks in vivo, and its hemostatic performance was comparable with that of an existing agent, Arista AH. Further clinical studies are required in the future.
Methods: Two separate animal experiments were performed. The first evaluated FBRs histologically at 3 days, 2 weeks, and 4 weeks, after implantation of OOZFIX in rats, and the second compared hemostatic performance of OOZFIX and Arista AH (Bard) in the porcine liver punch biopsy model.
Results: We found minimal FBRs in the 3-day group and no reactions in both the 2-week and 4-week groups after implantation of hemostatic agents. The time to hemostasis of OOZFIX was not significantly different from that of Arista AH (median [interquartile range]: 9 [6–10] minutes vs. 8 [6–10] minutes, respectively; P = 0.522). When comparing the serial bleeding grade tendency, there was no statistical difference between OOZFIX and Arista AH (P = 0.656).
Conclusion: OOZFIX caused a minimal FBR that disappeared within 2 weeks in vivo, and its hemostatic performance was comparable with that of an existing agent, Arista AH. Further clinical studies are required in the future.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Advances in the development of hemostatic biomaterials for medical application
생체재료학회지
2021 .12
-
In-vivo experiment for the efficacy of hemostatic agents in porcine liver punch biopsy model
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
ISO 10993 biological evaluation of novel hemostatic powder ? 4SEAL®
생체재료학회지
2022 .06
-
Hemostatic Materials during Operations
대한외과학회 학술대회 초록집
2017 .11
-
Clinical application of a new hemostatic material using mussel-inspired catecholamine hemostat: A pilot study
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .02
-
Endoscopic hemostatic powder as a salvage treatment for acute gastrointestinal bleeding
Clinical Endoscopy
2024 .09
-
Hemostatic materials in non-variceal upper gastrointestinal hemorrhage
International Journal of Gastrointestinal Intervention
2020 .01
-
Bleeding on the Edge?The Use of Hemostatic Powder for Treating a Bleeding Hypopharyngeal Tumor
Clinical Endoscopy
2021 .01
-
소화성 궤양 출혈의 내시경 치료
Korean Journal of Helicobacter Upper Gastrointestinal Research
2018 .01
-
Wound healing effect of regenerated oxidized cellulose versus fibrin sealant patch: An in vivo study
Archives of craniofacial surgery : ACFS
2019 .01
-
A multicenter, prospective, randomized clinical trial of marine mussel-inspired adhesive hemostatic materials, InnoSEAL Plus
Annals of Surgical Treatment and Research
2021 .11
-
Recent Developments in the Endoscopic Treatment of Patients with Peptic Ulcer Bleeding
Clinical Endoscopy
2016 .01
-
Effect of an aluminum chloride hemostatic agent on the dentin shear bond strength of a universal adhesive
Restorative Dentistry and Endodontics
2023 .05
-
Chitosan Pad, Cellulose Membrane, or Gelatin Sponge for Peridural Bleeding: An Efficacy Study on a Lumbar Laminectomized Rat Model
Asian Spine Journal
2018 .01
-
Comparative evaluation of the efficacy, safety, and hemostatic effect of 2% lidocaine with various concentrations of epinephrine
Journal of dental anesthesia and pain medicine
2018 .01
-
Letter to the Editor: A Prospective, Randomized, Controlled Comparative Study of Three Energy Devices in Open Thyroid Surgery: Thunderbeat, Harmonic, and Ligasure
The Journal of Endocrine Surgery
2020 .01
-
Evaluation of absorbable hemostatic clips with regarding to tissue adhesion and sealing effect of the abdomino-gynecologic surgery in rabbit model.
대한외과학회 학술대회 초록집
2017 .11
-
Efficacy evaluation of SurgiGuard® in partially hepatectomized pigs
Annals of Hepato-Biliary-Pancreatic Surgery
2016 .08
-
Comparison of hemostatic efficacy and cytotoxicity of three ferric subsulfate- and chitosan-based styptics in different formulations using a rat tail bleeding model
Korean Journal of Veterinary Research(대한수의학회지)
2018 .10
-
Risk Stratification in Cancer Patients with Acute Upper Gastrointestinal Bleeding: Comparison of Glasgow-Blatchford, Rockall and AIMS65, and Development of a New Scoring System
Clinical Endoscopy
2022 .03
이 논문의 저자 정보
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-ECN-0101-2023-514-000221228